Saturday’s Midday Stock Update: Teva Pharmaceutical Industries (TEVA), Recro Pharma (REPH), Glu Mobile (GLUU), Sangamo Biosciences (SGMO), Sarepta Therapeutics (SRPT)

By Carrie Williams

So far Saturday, November 9, NASDAQ is up 1.9% and the S&P is up 1.14%. Here are this morning’s most active stocks: Teva Pharmaceutical Industries (TEVAResearch Report), Recro Pharma (REPHResearch Report), Glu Mobile (GLUUResearch Report), Sangamo Biosciences (SGMOResearch Report) and Sarepta Therapeutics (SRPTResearch Report).

Teva Pharmaceutical Industries is up 9.03% in midday trading to $9.30. Shares opened today at $8.53. The company has a 52-week low of $6.07 and a 52-week high of $24.47. On the Street’s front, the average 12-month analyst price target for the stock is $8.67, marking a 1.64% potential upside from current levels. In a report released yesterday, Piper Jaffray analyst David Amsellem maintained a Hold rating on TEVA, with a price target of $7.00, which reflects a potential downside of -18% from last closing price. Separately, on October 22, Oppenheimer’s Esther Rajavelu reiterated a Buy rating on the stock and has a price target of $12.00. Over the last 3 months, the insider sentiment on Teva Pharmaceutical Industries has been negative based on 50 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Recro Pharma is up 6.73% in midday trading to $17.45. Shares opened today at $16.35. The company has a 52-week low of $5.53 and a 52-week high of $17.86. On the Street’s front, the average 12-month analyst price target for the stock is $17.67, marking a 8.07% potential upside from current levels. In a report released yesterday, Oppenheimer analyst Leland Gershell maintained a Buy rating on REPH, with a price target of $22.00, which represents a potential upside of 35% from where the stock is currently trading.

Glu Mobile is up 6.02% in midday trading to $5.81. Shares opened today at $5.48. The company has a 52-week low of $4.11 and a 52-week high of $11.75. On the Street’s front, the average 12-month analyst price target for the stock is $7.29, marking a 33.03% potential upside from current levels. In a report issued on November 7, Wedbush analyst Michael Pachter reiterated a Buy rating on GLUU, with a price target of $7.50, which represents a potential upside of 37% from where the stock is currently trading. Separately, on August 19, Roth Capital’s Darren Aftahi maintained a Hold rating on the stock and has a price target of $7.00. Over the last 3 months, the insider sentiment on Glu Mobile has been negative based on 41 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Sangamo Biosciences is up 5.91% in midday trading to $9.85. Shares opened today at $9.30. The company has a 52-week low of $6.26 and a 52-week high of $13.91. On the Street’s front, the average 12-month analyst price target for the stock is $13.50, marking a 45.16% potential upside from current levels. In a report issued on November 7, Cowen analyst Ritu Baral maintained a Buy rating on SGMO. Separately, on August 12, Wedbush’s Liana Moussatos reiterated a Hold rating on the stock and has a price target of $11.00.

Sarepta Therapeutics is up 5.8% in midday trading to $96.28. Shares opened today at $91.00. The company has a 52-week low of $72.05 and a 52-week high of $158.80. On the Street’s front, the average 12-month analyst price target for the stock is $191.07, marking a 109.97% potential upside from current levels. In a report released yesterday, RBC analyst Brian Abrahams maintained a Buy rating on SRPT, with a price target of $200.00, which implies an upside of 120% from current levels. Separately, on October 8, Oppenheimer’s Hartaj Singh maintained a Hold rating on the stock . Over the last 3 months, the insider sentiment on Sarepta Therapeutics has been positive based on 33 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Trending Stocks Based on Insider Activity >>